SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-330674
Filing Date
2012-08-02
Accepted
2012-08-02 09:59:27
Documents
3
Period of Report
2012-08-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d390356d8k.htm 8-K 15982
2 PRESS RELEASE d390356dex991.htm EX-99.1 56281
3 GRAPHIC g390356g93z47.jpg GRAPHIC 8548
  Complete submission text file 0001193125-12-330674.txt   85351
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23186 | Film No.: 121002095
SIC: 2836 Biological Products, (No Diagnostic Substances)